For a change, a China-based biopharma released a Q3 financial report that made investors happy, sending them out to buy the stock and push its price higher. 3SBio reported revenues that climbed 57% and profits that jumped a large 151%. The shares of 3SBio responded by gaining 16% in the first post-report session.  We look at the numbers... 

Stock Symbols: (NSDQ: SSRX) (NYSE: WX) (NYSE: TCM) (NYSE